Clinical trial NCT07668856
Status: RecruitingPhase 3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
- Record number
- NCT07668856
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 50
- Condition (as registered)
- Refractory Epilepsy in Children, Refractory Epilepsy, Epilepsy
- Countries
- Netherlands
- Topic in the guide
- Drug-Resistant Epilepsy
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: February 6, 2025
- End of data collection for primary results: November 2027 (expected)
- Trial completion: December 2027 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Drug-Resistant Epilepsy: ongoing trials · Thinking of taking part? Which specialist to see